1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - Any purpose.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [rumakhatun5005@gmail.com].
   


6. For how long will this data be available start date provided 01-01-2026 and end date provided 31-12-2030?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NA

Nasal turbinate hypertrophy is Hypertrophy (enlargement) of nasal turbinates. Inferior turbinate hypertrophy, a condition where the tissue on the lateral (outside) walls of the nose are too large, causing nasal obstruction. While the worldwide prevalence of inferior turbinate hypertrophy is unknown, a large study by Clark et al, of over 1900 patients with sinonasal complaints revealed that 72% suffered from hypertrophied turbinates. However, this narrowing of the nasal cavity affects the physiological functions of the nasal mucosa, causing problems such as mouth breathing, dry oropharynx, nasal talking, sleep disorders, snoring, nasal congestion, stuffy nose when lying down, and secretions Nasal congestion may affect general health also causes irritability, fatigue, decreased quality of life. The treatment of inferior turbinate hypertrophy has been actively debated for over a century. The main goal of treatment is to minimize the symptoms and extent of hypertrophy of ITH. Although not life-threatening, chronic nasal obstruction significantly impairs patient’s quality of life affecting their daily social and working activities. Though the use of homoeopathic medicines is extensive globally to treat the condition, Research on nasal ITH in homoeopathic treatment limited. There is a notable research gap in understanding the effect and mechanism of homoeopathic intervention for nasal ITH. This provides the basis for to conduct an open-label, single-arm trial on 50 participants suffering from nasal ITH  in adolescents and adults using individualized homoeopathic medicines (IHMs) in outpatient departments(OPD) especially ENT and PG2 of D.N.De Homoeopathic Medical College and Hospital , Govt. of WB; 12, Gobindo Khatick Road, Tangra, Kolkata, WB 700046. Primary outcome will be measured by  using Nasal Obstruction Symptom Evaluation (NOSE) score; Sino Nasal Outcome Test-22(SNOT-22),  Measure Yourself Medical Outcome Profile version2 (MYMOP-2) questionnaire will be the secondary outcome. All the outcomes will be measured every month up to 3 months. Pre-post changes will be measured using appropriate statistical tests. Results will be published in scientific journals.